Kim, J.; Chang, H.-S.; Yun, H.J.; Chang, H.-J.; Park, K.C.
New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer. Int. J. Mol. Sci. 2024, 25, 10646.
https://doi.org/10.3390/ijms251910646
AMA Style
Kim J, Chang H-S, Yun HJ, Chang H-J, Park KC.
New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer. International Journal of Molecular Sciences. 2024; 25(19):10646.
https://doi.org/10.3390/ijms251910646
Chicago/Turabian Style
Kim, Jungmin, Hang-Seok Chang, Hyeok Jun Yun, Ho-Jin Chang, and Ki Cheong Park.
2024. "New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer" International Journal of Molecular Sciences 25, no. 19: 10646.
https://doi.org/10.3390/ijms251910646
APA Style
Kim, J., Chang, H.-S., Yun, H. J., Chang, H.-J., & Park, K. C.
(2024). New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer. International Journal of Molecular Sciences, 25(19), 10646.
https://doi.org/10.3390/ijms251910646